Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief Report. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1161/atvbaha.116.307995
PubMed Identifier: 27856457
Publication URI: http://europepmc.org/abstract/MED/27856457
Type: Journal Article/Review
Volume: 37
Parent Publication: Arteriosclerosis, thrombosis, and vascular biology
Issue: 1
ISSN: 1079-5642